AB-CHMINACA
AB-CHMINACA is an indazole-based synthetic cannabinoid.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB 1 receptor (K i = 0.78 nM) and CB 2 receptor (K i = 0.45 nM) and fully substitutes for Δ 9 -THC in rat discrimination studies, while being 16x more potent.
Continuing the trend seen in other cannabinoids of this generation, such as AB-FUBINACA and AB-PINACA, it contains a valine amino acid amide residue as part of its structure, where older cannabinoids contained a naphthyl or adamantane residue.
AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB 1 receptor (K i = 0.78 nM) and CB 2 receptor (K i = 0.45 nM) and fully substitutes for Δ 9 -THC in rat discrimination studies, while being 16x more potent.
Continuing the trend seen in other cannabinoids of this generation, such as AB-FUBINACA and AB-PINACA, it contains a valine amino acid amide residue as part of its structure, where older cannabinoids contained a naphthyl or adamantane residue.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1355189699 under CC BY-SA 4.0; modifications have been made.